Key Takeaways

• Maharashtra accuses the central FSSAI of over‑reaching into state‑level food safety functions, prompting a legal showdown.
• The dispute landed in the Bombay High Court, where the state seeks a declaration that the central body cannot usurp the state FDA’s powers.
• The clash highlights deeper federal‑state tensions over regulatory jurisdiction, with potential ripple effects for India’s food‑safety ecosystem.
• Experts warn that prolonged litigation could delay critical inspections, affecting consumer confidence and industry compliance.

Background: FDA and FSSAI Roles

India’s food‑safety architecture is a two‑tiered system. At the national level, the Food Safety and Standards Authority of India (FSSAI) drafts standards, issues licenses, and enforces compliance across the country. At the state level, each state runs its own Food and Drug Administration (FDA), tasked with on‑ground inspections, local enforcement, and addressing region‑specific concerns.

While the Constitution grants the Centre the power to legislate on food safety under the Union List, states retain the right to implement and enforce those standards within their territories. This delicate balance has historically functioned through coordination committees, but recent political currents have strained the partnership.

The Spark: Maharashtra’s Accusations

In early September 2024, Maharashtra’s Health Ministry released a scathing statement alleging that the FSSAI had unilaterally issued directives that "encroached upon the statutory powers of the state FDA". Specific grievances included:

• Mandatory recall orders issued by FSSAI without prior consultation with the state FDA.
• Central‑issued inspection protocols that bypassed the state’s established audit mechanisms.
• Funding cuts to the state FDA, allegedly to pressure compliance with central mandates.

The state’s health minister, Anil Deshmukh, asserted that these moves amounted to a "direct usurpation of authority", jeopardising Maharashtra’s ability to safeguard its 120‑million‑strong population.

"The state will not cede its mandate to any central agency," Deshmukh told reporters during a press conference in Mumbai.

Legal Showdown: Bombay High Court Proceedings

Unable to resolve the dispute administratively, Maharashtra filed a public interest litigation (PIL) in the Bombay High Court on 12 September 2024. The petition seeks:

1. A declaratory order that the FSSAI cannot issue directives that override state FDA decisions.
2. An injunction against any ongoing central inspections in Maharashtra until a clear jurisdictional framework is established.
3. A mandate for a joint coordination committee with equal representation from the Centre and the state.

During the hearing on 5 October, the court heard arguments from both sides. The state counsel emphasized the constitutional principle of co‑operative federalism, while the central counsel argued that the FSSAI’s mandate, under the Food Safety and Standards Act, 2006, inherently supersedes state actions to ensure uniform standards.

The bench, led by Justice R. S. Bhosale, reserved judgment, indicating that the matter could set a precedent for inter‑governmental regulatory authority across India.

Political & Public Reaction

The standoff quickly spilled onto social media, with hashtags like #MaharashtraFDA and #FoodSafetyFederalism trending on Twitter and X. Consumer advocacy groups expressed concern that the legal tussle could delay critical food‑safety alerts, especially amid rising cases of adulterated products in urban markets.

Opposition parties in the Maharashtra Assembly seized the moment to criticize the central government’s “over‑centralisation” of power, while the ruling BJP framed the state’s move as an attempt to “shield local producers from national scrutiny.”

Implications for Food‑Safety Governance

The outcome of this case could reshape India’s regulatory landscape in several ways:

• Clarified Jurisdiction: A clear demarcation of powers would reduce future conflicts and streamline enforcement.
• Policy Harmonisation: Both levels might be compelled to develop a joint inspection protocol, balancing national standards with local nuances.
• Industry Impact: Food manufacturers operating across state lines could face dual compliance regimes, increasing operational costs.
• Consumer Trust: Prolonged disputes risk eroding public confidence in food‑safety agencies, potentially prompting calls for an independent oversight body.

Editorial Analysis & Future Outlook

The Maharashtra‑FSSAI clash is more than a bureaucratic squabble; it is a litmus test for India’s federal resilience in an era of increasingly centralized policymaking. If the Bombay High Court upholds the state’s claim, it could embolden other regions to assert greater autonomy over health‑related domains, from drug approvals to pandemic response.

Conversely, a ruling in favour of the FSSAI would reinforce the primacy of national standards, potentially accelerating the rollout of uniform food‑safety protocols but at the cost of local flexibility. In either scenario, the case underscores the necessity for a robust, collaborative framework that respects constitutional balances while safeguarding public health.

Looking ahead, stakeholders must prioritize institutional dialogue over litigation. A structured, transparent coordination mechanism—perhaps modelled after the National Disaster Management Authority’s state‑centre synergy—could preempt future disputes. Moreover, leveraging digital inspection platforms that share real‑time data between the FSSAI and state FDAs may offer a pragmatic solution, marrying national consistency with regional responsiveness.

In sum, the Maharashtra FDA vs FSSAI saga is a pivotal chapter in India’s evolving governance narrative. Its resolution will not only determine who holds the reins of food safety today but also set the tone for inter‑governmental cooperation in the health sector for years to come.

---

Original Reporting & Source: India Today Top Stories